Invesco Nasdaq Biotechnology ETF (IBBQ)
Invesco Nasdaq Biotechnology ETF operates in the Asset Management - Global industry of the Financial Services sector, headquartered in Downers Grove, IL, US. The stock last traded at $34.20, up 0.43% on the session, giving a market capitalisation of $81.0M. Its beta of 0.61 implies it has historically moved less than the broad market.
The Invesco Nasdaq Biotechnology ETF (IBBQ) seeks to mirror the investment performance of the Nasdaq Biotechnology Index. To achieve this, the Fund generally dedicates at least 90% of its total capital to the securities that make up this benchmark index. The underlying Index itself is specifically designed to gauge the returns of biotechnology and pharmaceutical companies whose shares are publicly traded on the Nasdaq Stock Market. Both the ETF and its corresponding Index undergo a yearly review and update of their composition each December, and their weightings are adjusted quarterly in March, June, September, and December.
Invesco Nasdaq Biotechnology ETF is most often compared with the following Financial Services names: